ADHD Clinical Trials in Irvine, California

4 studies are recruiting for adhd in Irvine, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

    This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in children aged 6 to <12 years with ADHD.

    Stage
    Phase 3
    Ages
    6 to 11
    Site
    Clinical Research Site, Irvine, California
    Locations
    23 in total
    Run by
    Axsome Therapeutics, Inc.

    See if you can join NCT07717879 on ClinicalTrials.gov

  2. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

    This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in adolescents aged 12 to <18 years with ADHD.

    Stage
    Phase 3
    Ages
    12 to 17
    Site
    Clinical Research Site, Irvine, California
    Locations
    24 in total
    Run by
    Axsome Therapeutics, Inc.

    See if you can join NCT07717892 on ClinicalTrials.gov

  3. Digital Health Intervention for Children With ADHD

    To conduct an RCT to evaluate the efficacy of the system, we will recruit 60 children (ages 8-12) with ADHD who will be randomized to either immediate (n=30) or delayed (n=30) treatment (i.e., a wait-list control group). Among those randomized to immediate treatment, half will be assigned to DHI (d…

    Stage
    Not phased
    Ages
    8 to 12
    Site
    The Craig School, Irvine, California
    Locations
    2 in total
    Run by
    University of California, Riverside

    See if you can join NCT06456372 on ClinicalTrials.gov

  4. AWARE: Management of ADHD in Autism Spectrum Disorder

    This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Using a sequential, multiple assignment randomization trial (SMART) design the study will…

    Stage
    Phase 4
    Ages
    4 to 17
    Site
    University of California, Irvine, Irvine, California
    Locations
    12 in total
    Run by
    Daniel Coury

    See if you can join NCT05916339 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.